# ERNA (Ernexa Therapeutics Inc.) - SEC EDGAR Financial Statements

> Ernexa Therapeutics Inc. reported $7.10M in total assets and a net loss of $13.96M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ERNA
- Markdown: https://convexityos.com/fundamentals/ERNA.md
- SEC CIK: 0000748592
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000748592&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$14.78M | Operating profit |
| Net Income | FY 2025 | -$13.96M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$8.95 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$7.05M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $5.58M | Total debt: $309K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | $582K | $68K | $0 | -- | $5.80M | $19.81M | $23.34M | $21.27M | $22.31M |
| Cost of Revenue | -- | $96K | $236K | $0 | -- | -- | -- | -- | -- | -- |
| **Gross Profit** | -- | $486K | -$168K | $0 | -- | -- | -- | -- | -- | -- |
| Research & Development | $4.16M | $4.60M | $5.92M | $10.39M | $12.71M | $2.0K | $26K | $72K | $139K | -- |
| Selling, General & Admin | -- | -- | -- | -- | -- | $8.09M | $13.18M | $14.46M | $15.59M | $16.46M |
| Total Operating Expenses | $9.32M | $16.16M | $20.97M | $33.22M | $113.7M | $26.49M | $21.57M | $23.13M | $22.68M | $24.59M |
| **Operating Income** | -$9.32M | -$15.67M | -$21.14M | -$33.22M | -$113.7M | -$26.49M | -$1.76M | $203K | -$1.40M | -$2.28M |
| **EBITDA** | -$9.25M | -$15.54M | -$21.05M | -$33.06M | -$113.6M | -$26.39M | $1.11M | $2.97M | $915K | $609K |
| Interest Income | $100K | $200K | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest Expense | -$100K | -$6.80M | $614K | $30K | -- | $118K | $236K | $296K | $425K | $517K |
| Income Before Tax | -$14.13M | -$44.51M | -$21.67M | -$24.53M | -$122.5M | -$26.53M | -$2.02M | -$323K | -$1.01M | -$2.88M |
| Income Tax Expense | -$45K | $30K | -$3.0K | $45K | $64K | $0 | $27K | -$64K | $66K | $38K |
| **Net Income** | -$14.08M | -$44.54M | -$21.67M | -$24.58M | -$122.5M | -$26.53M | -$2.05M | -$259K | -$1.08M | -$2.92M |
| Basic EPS | -$20,740.74 | -$453,333.33 | -$566,666.67 | -$1,119,444.44 | -$7,862,500.00 | -$4,194,444.44 | -$4,000,000.00 | -$555,555.56 | -$2,500,000.00 | -$8,555,555.56 |
| **Diluted EPS** | -$20,740.74 | -$453,333.33 | -$566,666.67 | -$1,119,444.44 | -$7,862,500.00 | -$4,194,444.44 | -$4,000,000.00 | -$555,555.56 | -$2,500,000.00 | -$8,555,555.56 |
| Basic Shares Outstanding | 681 | 98 | 38 | 22 | 16 | 6 | 0 | 0 | 0 | 0 |
| Diluted Shares Outstanding | 681 | 98 | 38 | 22 | 16 | 6 | 0 | 0 | 0 | 0 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | -- | $1.0K |
| Cost of Revenue | $0 | $0 | -- | -- | $0 | $0 | -- | $0 |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | -- | $1.0K |
| Research & Development | $1.87M | $2.79M | $1.92M | $676K | $1.03M | $1.14M | $1.31M | $1.16M |
| Total Operating Expenses | $2.99M | $4.10M | $5.59M | $2.09M | $1.99M | $2.50M | $2.73M | $2.70M |
| **Operating Income** | -$2.99M | -$4.10M | -$5.59M | -$2.09M | -$1.99M | -$2.50M | -$2.73M | -$2.70M |
| **EBITDA** | -$2.98M | -$4.09M | -$5.58M | -$2.08M | -$1.98M | -$2.48M | -$2.71M | -$2.68M |
| Interest Income | $49K | $55K | $44K | -- | -- | -- | $5.0K | -- |
| Interest Expense | -- | -- | -- | $0 | $0 | $16K | $800K | -$10.10M |
| Income Before Tax | -$2.94M | -$4.01M | -$5.55M | -$1.56M | -$1.23M | -$3.14M | -$8.19M | -$5.75M |
| Income Tax Expense | $0 | $0 | -$40K | -$62K | $6.0K | $3.0K | $8.0K | $11K |
| **Net Income** | -$2.94M | -$4.01M | -$5.51M | -$1.50M | -$1.24M | -$3.14M | -$8.20M | -$5.76M |
| Basic EPS | -$1.89 | -$3.40 | -$173.75 | -- | -$3.77 | -$15.19 | -$1,444.00 | -- |
| **Diluted EPS** | -$1.89 | -$3.40 | -$173.75 | -- | -$3.77 | -$15.19 | -$1,444.00 | -- |
| Basic Shares Outstanding | 1.6M | 1.2M | 31.7K | -- | 329.0K | 207.0K | 5.7K | -- |
| Diluted Shares Outstanding | 1.6M | 1.2M | 31.7K | -- | 329.0K | 207.0K | 5.7K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.88M | $1.73M | $7.58M | $11.45M | $16.98M | $777K | $3.21M | $2.54M | $3.38M | $5.69M |
| **Cash & Short-Term Investments** | $1.88M | $1.73M | $7.58M | $11.45M | $16.98M | $777K | $3.21M | $2.54M | $3.38M | $5.69M |
| Accounts Receivable, Net | -- | -- | -- | -- | $684K | $0 | $1.20M | $1.14M | $714K | $928K |
| **Total Current Assets** | $3.13M | $2.35M | $9.60M | $13.68M | $18.77M | $1.73M | $6.07M | $6.79M | $9.64M | $10.66M |
| Property, Plant & Equipment, Net | $94K | $85K | $493K | $236K | $670K | $594K | $2.82M | $4.67M | $3.68M | $3.10M |
| Goodwill | $2.04M | $2.04M | $2.04M | $2.04M | $2.04M | $2.04M | $696K | $667K | $1.00M | $937K |
| Intangible Assets | -- | -- | -- | -- | -- | -- | $696K | $667K | $1.00M | $29K |
| Other Non-Current Assets | $110K | $118K | $120K | $1.13M | $488K | $50K | $97K | $103K | $16K | $92K |
| **Total Non-Current Assets** | $2.70M | $2.92M | $39.53M | $8.60M | $12.76M | $12.04M | $8.05M | $8.08M | $6.93M | $6.03M |
| **Total Assets** | $5.83M | $5.27M | $49.13M | $22.28M | $31.52M | $13.78M | $14.12M | $14.86M | $16.57M | $16.70M |
| Accounts Payable | $1.12M | $1.72M | $1.07M | $1.62M | $1.75M | $1.27M | $835K | $271K | $390K | $247K |
| Short-Term Debt | -- | -- | -- | -- | -- | $1.50M | $2.74M | $1.00M | $5.06M | $2.99M |
| Deferred Revenue (Current) | -- | -- | $190K | $0 | -- | $76K | $460K | $1.37M | $3.56M | $1.06M |
| Other Current Liabilities | $83K | -- | $1.21M | $363K | $247K | $0 | $419K | $337K | $192K | $291K |
| **Total Current Liabilities** | $3.11M | $2.94M | $6.57M | $7.65M | $3.68M | $3.12M | $6.09M | $4.02M | $10.75M | $6.64M |
| Long-Term Debt | -- | -- | -- | -- | -- | $532K | -- | $2.75M | $64K | $5.12M |
| Deferred Revenue (Non-Current) | -- | -- | $392K | $0 | -- | $2.0K | $2.0K | $30K | $63K | $219K |
| Other Non-Current Liabilities | $43K | $111K | $84K | $94K | $48K | $23K | $26K | -- | $52K | $12K |
| **Total Non-Current Liabilities** | $320K | $630K | $40.33M | $2.52M | $2.35M | $22.23M | $2.94M | $3.92M | $287K | $5.98M |
| **Total Liabilities** | $3.43M | $3.57M | $46.90M | $10.17M | $6.02M | $25.36M | $9.03M | $7.95M | $11.03M | $12.63M |
| **Total Debt (incl. Leases)** | $490K | $684K | $35.07M | $1.18M | $2.72M | $4.23M | $6.08M | $7.29M | $5.12M | $8.11M |
| Common Stock | $2.0K | $17K | $27K | $26K | $13K | $0 | $14K | $14K | $13K | $11K |
| Retained Earnings | -$245.6M | -$231.5M | -$187.0M | -$165.3M | -$140.7M | -$37.38M | -$131.5M | -$129.4M | -$129.1M | -$128.0M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | $245K | $268K | $200K | $345K | $223K |
| **Total Stockholders' Equity** | $2.40M | $1.70M | $2.23M | $12.11M | $25.50M | $7.66M | $9.74M | $6.92M | $5.54M | $4.07M |
| Total Equity | $2.40M | $1.70M | $2.23M | $12.11M | $25.50M | $7.66M | $9.74M | $6.92M | $5.54M | $4.07M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.58M | $5.03M | $9.18M | $1.88M | $3.05M | $4.32M | $1.92M | $1.73M |
| **Cash & Short-Term Investments** | $5.58M | $5.03M | $9.18M | $1.88M | $3.05M | $4.32M | $1.92M | $1.73M |
| **Total Current Assets** | $6.73M | $5.89M | $10.00M | $3.13M | $3.38M | $4.79M | $2.21M | $2.35M |
| Property, Plant & Equipment, Net | $73K | $82K | $88K | $94K | $92K | $50K | $67K | $85K |
| Goodwill | -- | -- | -- | $2.04M | $2.04M | $2.04M | $2.04M | $2.04M |
| Other Non-Current Assets | $25K | $25K | $110K | $110K | $116K | $117K | $118K | $118K |
| **Total Non-Current Assets** | $376K | $421K | $547K | $2.70M | $2.79M | $2.79M | $2.85M | $2.92M |
| **Total Assets** | $7.10M | $6.32M | $10.54M | $5.83M | $6.17M | $7.58M | $5.06M | $5.27M |
| Accounts Payable | $1.36M | $1.38M | $1.30M | $1.12M | $958K | $1.32M | $1.27M | $1.72M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | $5.33M | -- |
| Other Current Liabilities | -- | $124K | $218K | $83K | $63K | $125K | -- | -- |
| **Total Current Liabilities** | $2.61M | $2.93M | $3.46M | $3.11M | $2.14M | $2.65M | $10.44M | $2.94M |
| Other Non-Current Liabilities | $1.0K | $1.0K | $1.0K | $43K | $112K | $113K | $111K | $111K |
| **Total Non-Current Liabilities** | $139K | $183K | $227K | $320K | $458K | $489K | $571K | $630K |
| **Total Liabilities** | $2.75M | $3.12M | $3.68M | $3.43M | $2.60M | $3.14M | $11.01M | $3.57M |
| **Total Debt (incl. Leases)** | $309K | $349K | $389K | $490K | $552K | $593K | $632K | $684K |
| Common Stock | $8.0K | $6.0K | $6.0K | $2.0K | $39K | $37K | $262K | $17K |
| Retained Earnings | -$258.1M | -$255.2M | -$251.1M | -$245.6M | -$244.1M | -$242.9M | -$239.7M | -$231.5M |
| **Total Stockholders' Equity** | $4.35M | $3.20M | $6.86M | $2.40M | $3.57M | $4.44M | -$5.95M | $1.70M |
| Total Equity | $4.35M | $3.20M | $6.86M | $2.40M | $3.57M | $4.44M | -$5.95M | $1.70M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$14.08M | -$44.54M | -$21.67M | -$24.58M | -$122.5M | -$26.53M | -$2.05M | -$259K | -$1.08M | -$2.92M |
| Depreciation & Amortization | $65K | $139K | $84K | $161K | $117K | $98K | $2.88M | $2.76M | $2.32M | $2.89M |
| Stock-Based Compensation | $1.50M | $1.52M | $1.24M | $2.94M | $5.24M | $91K | $206K | $443K | $457K | $419K |
| Change in Receivables | -- | -- | -- | -- | -$659K | $0 | -$248K | -$507K | $142K | -$83K |
| **Operating Cash Flow** | -$7.02M | -$15.84M | -$20.41M | -$20.98M | -$23.49M | -$8.10M | $2.74M | $1.36M | $549K | $23K |
| Capital Expenditure | -$37K | -$369K | -$19K | -$297K | -$154K | -$39K | -$128K | -$648K | -$728K | -$427K |
| **Free Cash Flow** | -$7.05M | -$16.20M | -$20.43M | -$21.27M | -$23.64M | -$8.14M | $2.62M | $717K | -$179K | -$404K |
| **Investing Cash Flow** | -$37K | -$365K | -$19K | -$47K | -$22.74M | -$39K | -$1.06M | -$1.58M | -$1.45M | -$840K |
| Common Stock Issued | $4.93M | $1.14M | $0 | $19.71M | $0 | $0 | -- | $1.38M | $1.77M | $2.69M |
| **Financing Cash Flow** | $7.21M | $6.26M | $16.56M | $19.58M | $61.59M | $4.67M | -$1.10M | -$303K | -$1.47M | $3.26M |
| **Net Change in Cash** | $155K | -$9.94M | -$3.87M | -$1.44M | $15.36M | -$2.63M | $623K | -$592K | -$2.37M | $2.44M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.94M | -$4.01M | -$5.51M | -$1.50M | -$1.24M | -$3.14M | -$8.20M | -$5.76M |
| Depreciation & Amortization | $10K | $9.0K | $8.0K | $13K | $17K | $17K | $18K | $19K |
| Stock-Based Compensation | $375K | $320K | $309K | $333K | $293K | $368K | $502K | $410K |
| **Operating Cash Flow** | -$3.17M | -$4.15M | -$2.26M | -$1.15M | -$1.27M | -$2.53M | -$2.06M | -$3.54M |
| Capital Expenditure | $0 | -$3.0K | -$2.0K | -- | -- | -- | -- | $0 |
| **Free Cash Flow** | -$3.17M | -$4.16M | -$2.27M | -- | -- | -- | -- | -$3.54M |
| **Investing Cash Flow** | $0 | -$3.0K | -$2.0K | -- | -- | -- | -- | $0 |
| Common Stock Issued | -- | -- | $10.48M | -- | -- | $7.20M | -- | -- |
| **Financing Cash Flow** | $3.72M | $6.0K | $9.56M | $0 | $26K | $4.93M | $2.25M | $1.01M |
| **Net Change in Cash** | $547K | -$4.15M | $7.29M | -$1.16M | -$1.27M | $2.40M | $189K | -$2.54M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | 83.5% | -247.1% | -- | -- | -- | -- | -- | -- | -- |
| **Operating Margin** | -- | -2693.1% | -31080.9% | -- | -- | -456.7% | -8.9% | 0.9% | -6.6% | -10.2% |
| **Net Profit Margin** | -- | -7652.7% | -31864.7% | -- | -- | -457.4% | -10.3% | -1.1% | -5.1% | -13.1% |
| Return on Equity (ROE) | -586.6% | -2618.4% | -970.4% | -203.0% | -480.5% | -346.4% | -21.0% | -3.7% | -19.5% | -71.9% |
| Return on Assets (ROA) | -241.4% | -845.3% | -44.1% | -110.3% | -388.7% | -192.6% | -14.5% | -1.7% | -6.5% | -17.5% |
| Current Ratio | 1.01x | 0.80x | 1.46x | 1.79x | 5.10x | 0.55x | 1.00x | 1.69x | 0.90x | 1.60x |
| Quick Ratio | 0.61x | 0.59x | 1.15x | 1.50x | 4.81x | 0.25x | 0.72x | 0.91x | 0.38x | 1.00x |
| Debt to Equity | 0.20x | 0.40x | 15.71x | 0.10x | 0.11x | 0.55x | 0.62x | 1.05x | 0.93x | 1.99x |
| **Revenue Growth (YoY)** | -- | +755.9% | -- | -- | -- | -70.7% | -15.1% | +9.7% | -4.7% | -9.0% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -968.0% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -395.2% | +101.0% | +148.6% | +2287.0% | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -411.2% | +264.9% | -- | -- | -- |
| 10Y Revenue / Share Growth | -- | -- | -99.9% | -- | -- | -58.0% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | -- | 83.5% |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -- | -2693.1% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -- | -7652.7% |
| Return on Equity (ROE) | -320.8% | -383.0% | -166.0% | -586.5% | -513.7% | -983.7% | -- | -2618.4% |
| Return on Assets (ROA) | -196.5% | -194.1% | -108.0% | -241.4% | -297.1% | -576.3% | -911.1% | -845.3% |
| Current Ratio | 2.57x | 2.01x | 2.89x | 1.01x | 1.58x | 1.81x | 0.21x | 0.80x |
| Quick Ratio | 2.13x | 1.71x | 2.65x | 0.61x | 1.42x | 1.63x | 0.18x | 0.59x |
| Debt to Equity | 0.07x | 0.11x | 0.06x | 0.20x | 0.15x | 0.13x | -- | 0.40x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -94.1% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
